zyban (R)
FREE subscriptions for doctors and students... click here
You have 3 more open access pages.
- Zyban is the slow-release form of the antidepressant bupropion - it is the first antidepressant licensed for smoking cessation
- unlike nicotine replacement therapy, treatment is started two weeks before quitting smoking
- one hypothesis suggests that Zyban might work in smoking cessation by increasing levels of noradrenaline and dopamine in the brain. This therefore counteracts the reductions in these neurochemicals that results from nicotine withdrawal
The summary of product characteristics should be consulted before prescribing this drug.
Last reviewed 11/2020
Links:
- cautions and contraindications
- pharmacology
- dose and administration
- drug interactions
- side effects
- efficacy
- NICE guidance - use of nicotine replacement therapy (NRT) , varenicline and bupropion for smoking cessation
- smoking cessation
- naltrexone / bupropion in obesity
- bupropion (Zyban) - risk of serotonin syndrome with use with other serotonergic drugs